Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CMA1 | P23946 | 1/20 | 0.48 |
| ▸ | AGXT | P21549 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL10445073 | 0.98 | TAAR1 (0.52) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL11536085 | 0.81 | IDO1 (0.56) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL1797282 | 0.78 | TAAR1 (0.61) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL363725 | 0.77 | IDO1 (0.52) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL5254359 | 0.77 | IDO1 (0.52) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL2390804 | 0.77 | ALDH1A1 (0.50) | TAAR1ALDH1A1TSHRCALM1 | |
| Bromide SCHEMBL10874061 | 0.76 | IDO1 (0.50) | TAAR1IDO1CA12CA1CA2 | |
| SCHEMBL227516 | 0.75 | TAAR1 (0.59) | TAAR1IDO1MAOBALDH1A1CMA1 | |
| SCHEMBL558967 | 0.73 | TAAR1 (0.48) | TAAR1IDO1CA2ALDH1A1TP53 | |
| SCHEMBL560202 | 0.73 | CYP1A2 (0.48) | TAAR1IDO1ALDH1A1MAPTAGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| CN-112047919-A | Ticagrelor intermediate and preparation method thereof | 常州制药厂有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-100548950-C | Process for preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS INC (US) | 2009-10-14 | — | — | CN | claimed |
| US-7273948-B2 | Process of preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS, INC. (US) | 2007-09-25 | — | — | US | claimed |
| EP-1594824-A4 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS INC (US) | 2007-04-04 | — | — | EP | claimed |
| CN-1759084-A | Process for preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS INC (US) | 2006-04-12 | — | — | CN | claimed |
| EP-1594824-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | Atherogenics, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | CRABTREE ACQUISITION CO, LLC | 2004-10-14 | — | — | US | claimed |
| WO-2004062622-A2 | PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF | ATHEROGENICS, INC. (US) | 2004-07-29 | — | — | WO | claimed |
| US-20260042736-A1 | COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES | Board of Regents of Nevada System of Higher Education on behalf of the University of Nevada Reno (US) | 2026-02-12 | — | — | US | disclosed |
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| US-12049461-B2 | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections | GILEAD SCIENCES, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| CN-116102407-B | Method for preparing gastrodia elata extract 2, 4-bis (4-hydroxybenzyl) phenol | 北京化工大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-112789108-B | Catalyst for asymmetric hydrogenation of compounds containing carbon double bonds | 格拉斯如睦株式会社 | 2023-09-19 | — | — | CN | disclosed |
| EP-0005980-A2 | Derivatives of substituted N-alkyl imidazoles, their preparation and these compounds for pharmaceutical use | SYNTEX (U.S.A.) INC. (US) | 1979-12-12 | — | — | EP | disclosed |
| US-4105659-A | ANTAGONISTS, ANALGESICS | STERLING DRUG INC. (US) | 1978-08-08 | — | — | US | disclosed |
| US-4070360-A | ANALGESICS | MERCK & CO., INC. (US) | 1978-01-24 | — | — | US | disclosed |
| US-4070359-A | ISOMERIZATION, CYCLIZATION, ANALGESICS | MERCK & CO., INC. (US) | 1978-01-24 | — | — | US | disclosed |
| US-4033968-A | ANALGESICS | MERCK & CO., INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-3961066-A | ANALGESICS, ANTITUSSIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049461-B2 | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections | NR3C1, NR3C2, NR4A1 | TAAR1 319/4885IDO1 1289/4885CA12 4586/4885 |
| US-20260042736-A1 | COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES | TDO2, SCO2, TPH1 | TAAR1 1868/4885IDO1 8/4885CA12 2255/4885 |
| US-20040204485-A1 | Process of preparing esters and ethers of probucol and derivatives thereof | NR3C2, MGLL, GCG | TAAR1 3193/4885IDO1 4697/4885CA12 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.